Italy

Sales & Marketing

pharmaphorum podcast Episode 268 - Andrea Carta Mantiglia, BonelliErede

BonelliErede on M&A in Europe: Andrea Carta Mantiglia

Andrea Carta Mantiglia, partner and lead of the Healthcare & Life Sciences Focus Team at Italian law firm BonelliErede, discusses M&A in Europe.

Digital

What US healthcare companies and medical researchers need to...

How Italy’s pioneering AI Law and the EU AI Act impacts US healthcare companies and medical researchers operating in Italy.

News

Chiesi backs growth plans with a €430m new plant in Italy

Fast-growing pharma group Chiesi has revealed plans to spend €430m on a new therapeutics manufacturing facility at its site in Milan.

News

Italian decision sets up launch of Oncopeptides' Pepaxti

Oncopeptides hopes to reignite growth in multiple myeloma drug Pepaxti after getting reimbursement approval in Italy.

News

Chiesi Biotech Center of Excellence opens to strengthen R&D ...

Chiesi Group has today officially launched its new Biotech Center of Excellence, with the aim that it "brings the future of medicine to Parma."

News

Italy starts probe into Lucentis biosimilar delay allegation

Italy’s antitrust authority has launched an investigation against eight pharma companies, including Novartis and Roche, over suspicion they may have colluded to delay the

BonelliErede on M&A in Europe: Andrea Carta Mantiglia

What US healthcare companies and medical researchers need to...

Chiesi backs growth plans with a €430m new plant in Italy

Italian decision sets up launch of Oncopeptides' Pepaxti

Chiesi Biotech Center of Excellence opens to strengthen R&D ...

Italy starts probe into Lucentis biosimilar delay allegation

Lundbeck preps for key bexicaserin data around year-end

Discover a new era of healthcare panel engagement: Grounded ...

Italy

Editor's Picks